First patient treated in US trial of renal pelvic denervation technology
Verve Medical has announced successful treatment of the first patient in its randomised, double‑blinded US pilot clinical trial using its renal pelvic denervation technology...
EMA grants PRIME designation for MIC-Lx therapy for donor-specific immune tolerance in kidney transplantation
The European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to TolerogenixX lead cell therapy candidate MIC-Lx for individualised immuno-suppression in living donor...
Fish oil supplement could reduce cardiovascular events in patients receiving dialysis
A daily fish oil supplement may significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure.
The findings come from a major international...
VentureMed changes operating name to Flex Vascular
VentureMed, the company behind the FLEX Vessel Prep system for arteriovenous (AV) access and peripheral arterial disease (PAD) interventions, is now doing business as Flex...
